Literature DB >> 12221455

Primary stenting as emergency therapy in acute basilar artery occlusion.

Joachim Spreer1, Thomas Els, Andreas Hetzel, Sebastian Arnold, Joachim Klisch, Hans-Jürgen Huppertz, Eckhardt Oehm, Martin Schumacher.   

Abstract

In three patients with acute occlusion of the basilar artery intra-arterial fibrinolysis resulted in only partial recanalization and revealed severe stenosis as the underlying cause. Application of micro-stents without previous dilatation resulted in vessel re-opening. Two patients had an excellent clinical outcome. One patient died 10 days after the stroke due to brainstem infarction. Emergency primary stent application may improve the outcome in acute basilar artery occlusion, if intra-arterial thrombolysis fails to re-establish a sufficient flow.

Entities:  

Mesh:

Year:  2002        PMID: 12221455     DOI: 10.1007/s00234-002-0798-7

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  4 in total

Review 1.  Basilar artery occlusion.

Authors:  Tracey A Baird; Keith W Muir; Ian Bone
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

2.  [Interventional endovascular therapy (stenting) for residual stenosis after lysis of the basilar artery].

Authors:  S Boy; K Isenhardt; K Gardill; B Kapp; R Schneider; J Berkefeld
Journal:  Nervenarzt       Date:  2005-12       Impact factor: 1.214

3.  Endovascular recanalization of acute intracranial vertebrobasilar artery occlusion using local fibrinolysis and additional balloon angioplasty.

Authors:  Junji Kashiwagi; Hiro Kiyosue; Yuzo Hori; Mika Okahara; Shuichi Tanoue; Yoshiko Sagara; Toshi Abe; Hiromu Mori
Journal:  Neuroradiology       Date:  2010-01-30       Impact factor: 2.804

4.  Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis.

Authors:  M Arnold; K Nedeltchev; G Schroth; R W Baumgartner; L Remonda; T J Loher; F Stepper; M Sturzenegger; B Schuknecht; H P Mattle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.